MAPT and Alzheimer disease: Another recent study (Martá-Ariza et al., 2025) evaluated the Aβ plaque proteome in four cohorts—ADAD, late-onset AD, DSAD, and controls—finding significantly increased amyloid-β and tau pathologies in DS, but no significant sex effects on proteomic profiles.